Hyperalgesic activity of kisspeptin in mice

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Spampinato, Simona ^a   Trabucco, Angela ^b   Biasiotta, Antonella ^c   Biagioni, Francesca ^b   Cruccu, Giorgio ^c   Copani, Agata ^a   Colledge, William H ^d   Sortino, Maria A ^a   Nicoletti, Ferdinando ^b,c   Chiechio, Santina ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Gpr54; Inflammatory pain; Kisspeptin; Nociceptive sensitization

Indexed keywords

[4 [2 CYCLOPENTYL 9 (3 HYDROXYPHENETHYL)PURIN 6 YLAMINO]PHENYL]DIMETHYLPHOSPHINE OXIDE; FORMALDEHYDE; G PROTEIN COUPLED RECEPTOR 54; KISSPEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 3; P 234; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; KISS1R PROTEIN, MOUSE; NEUROPEPTIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYPERALGESIA; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SKIN BIOPSY; SPINAL CORD DORSAL HORN; SPINAL GANGLION; WILD TYPE; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOUSE STRAIN; PATHOPHYSIOLOGY;

ANIMALS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPERALGESIA; KISSPEPTINS; MALE; MICE; MICE, INBRED STRAINS; NEUROPEPTIDES; PAIN THRESHOLD; RECEPTORS, G-PROTEIN-COUPLED;

EID: 81555230341     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-90     Document Type: Article

References (56)

1. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996, 88:1731-1737. 10.1093/jnci/88.23.1731, 8944003.
2. Seminara SB. Mechanisms of Disease: the first kiss-a crucial role for kisspeptin-1 and its receptor, G-protein-coupled receptor 54, in puberty and reproduction. Nat Clin Pract Endocrinol Metab 2006, 2:328-334. 10.1038/ncpendmet0139, 16932310.
3. Kauffman AS, Clifton DK, Steiner RA. Emerging ideas about kisspeptin- GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci 2007, 30:504-511. 10.1016/j.tins.2007.08.001, 17904653.
4. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol Metab 2009, 20:115-21. 10.1016/j.tem.2008.10.005, 19097915.
5. Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 2010, 151:3479-3489. 10.1210/en.2010-0022, 2940527, 20501670.
6. Arai AC, Orwig N. Factors that regulate KiSS1 gene expression in the hippocampus. Brain Res 2008, 1243:10-8.
7. Arai AC. The role of kisspeptin and GPR54 in the hippocampus. Peptides 2009, 30:16-25. 10.1016/j.peptides.2008.07.023, 18765263.
8. Gottsch ML, Clifton DK, Steiner RA. Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive axis. Mol Cell Endocrinol 2006, 254-255:91-6.
9. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003, 100:10972-10976. 10.1073/pnas.1834399100, 196911, 12944565.
10. Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev 2009, 30:713-743. 10.1210/er.2009-0005, 2761114, 19770291.
11. Dun SL, Brailoiu GC, Parsons A, Yang J, Zeng Q, Chen X, Chang JK, Dun NJ. Metastin-like immunoreactivity in the rat medulla oblongata and spinal cord. Neurosci Lett 2003, 335:197-201. 10.1016/S0304-3940(02)01191-6, 12531466.
12. Mi WL, Mao-Ying QL, Liu Q, Wang XW, Li X, Wang YQ, Wu GC. The distribution of kisspeptin and its receptor GPR54 in rat dorsal root ganglion and up-regulation of its expression after CFA injection. Brain Res Bull 2009, 78:254-260. 10.1016/j.brainresbull.2008.12.003, 19111911.
13. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N Engl J Med 2003, 349:1614-1627. 10.1056/NEJMoa035322, 14573733.
14. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995, 45:1848-1855.
15. Jin L, Miyamoto O, Toyoshima T, Kobayashi R, Murakami TH, Itano T. Localization of calbindin-D28k in normal and incised mouse skin: immunohistochemical and immunoblot analysis. Arch Dermatol Res 1997, 289:578-84. 10.1007/s004030050243, 9373717.
16. Pheng V, Uenoyama Y, Homma T, Inamoto Y, Takase K, Yoshizawa-Kumagaye K, Isaka S, Watanabe TX, Ohkura S, Tomikawa J, Maeda K, Tsukamura H. Potencies of centrally- or peripherally-injected full-length kisspeptin or its C-terminal decapeptide on LH release in intact male rats. J Reprod Dev 2009, 55:378-82. 10.1262/jrd.20240, 19384054.
17. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992, 12:3665-3670.
18. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992, 51:5-17. 10.1016/0304-3959(92)90003-T, 1454405.
19. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, Pineda R, Gottsch ML, Tena-Sempere M, Moenter SM, Terasawa E, Clarke IJ, Steiner RA, Millar RP. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 2009, 29:3920-9. 10.1523/JNEUROSCI.5740-08.2009, 3035813, 19321788.
20. Hucho T, Levine JD. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007, 55:365-76. 10.1016/j.neuron.2007.07.008, 17678851.
21. Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM. Roles of transient receptor potential channels in pain. Brain Res Rev 2009, 60:2-23. 10.1016/j.brainresrev.2008.12.018, 2683630, 19203589.
22. Studer M, McNaughton PA. Modulation of single-channel properties of TRPV1 by phosphorylation. J Physiol 2010, 588:3743-3756. 10.1113/jphysiol.2010.190611, 2998224, 20693293.
23. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543. 10.1016/S0896-6273(00)80564-4, 9768840.
24. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001, 98:6951-6956. 10.1073/pnas.111025298, 34459, 11371611.
25. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408:985-990. 10.1038/35050121, 11140687.
26. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001, 77:1660-1663. 10.1046/j.1471-4159.2001.00406.x, 11413249.
27. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35:721-731. 10.1016/S0896-6273(02)00802-4, 12194871.
28. Hu HJ, Bhave G, Gereau RW. Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor5: potential mechanism for thermal hyperalgesia. J Neurosci 2002, 22:7444-7452.
29. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, Nau C, Kress M. PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002, 22:4740-4745.
30. Sugiura T, Tominaga M, Katsuya H, Mizumura K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor1. J Neurophysiol 2002, 88:544-548.
31. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci USA 2003, 100:12480-12485. 10.1073/pnas.2032100100, 218783, 14523239.
32. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, Tominaga M, Noguchi K. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004, 24:4293-4299. 10.1523/JNEUROSCI.0454-04.2004, 15128843.
33. Jung J, Shin JS, Lee SY, Hwang SW, Koo J, Cho H, Oh U. Phosphorylation of vanilloid receptor1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 2004, 279:7048-7054.
34. Jin X, Morsy N, Winston J, Pasricha PJ, Garrett K, Akbarali HI. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 2004, 287:C558-563. 10.1152/ajpcell.00113.2004, 15084474.
35. Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase C epsilon and identification of two target serine residues. J Biol Chem 2002, 277:13375-13378. 10.1074/jbc.C200104200, 11884385.
36. Numazaki M, Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord 2004, 3:479-485. 10.2174/1568007043336789, 15578965.
37. Mandadi S, Tominaga T, Numazaki M, Murayama N, Saito N, Armati PJ, Roufogalis BD, Tominaga M. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain 2006, 123:106-116. 10.1016/j.pain.2006.02.016, 16564619.
38. Bhave G, Karim F, Carlton SM, Gereau RW. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001, 4:417-23. 10.1038/86075, 11276233.
39. Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RW. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci 2007, 27:13181-91. 10.1523/JNEUROSCI.0269-07.2007, 18045912.
40. Moriyama T, Iida T, Kobayashi K, Higashi T, Fukuoka T, Tsumura H, Leon C, Suzuki N, Inoue K, Gachet C, Noguchi K, Tominaga M. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 2003, 23:6058-6062.
41. Ferreira J, da Silva GL, Calixto JB. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 2004, 141:787-94. 10.1038/sj.bjp.0705546, 1574249, 14967737.
42. Vellani V, Colucci M, Lattanzi R, Giannini E, Negri L, Melchiorri P, McNaughton PA. Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8. J Neurosci 2006, 26:5109-5116. 10.1523/JNEUROSCI.3870-05.2006, 16687502.
43. Negri L, Lattanzi R, Giannini E, Colucci M, Margheriti F, Melchiorri P, Vellani V, Tian H, De Felice M, Porreca F. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci 2006, 26:6716-27. 10.1523/JNEUROSCI.5403-05.2006, 16793879.
44. Malin SA, Davis BM, Koerber HR, Reynolds IJ, Albers KM, Molliver DC. Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2. Pain 2008, 138:484-96. 10.1016/j.pain.2008.01.026, 2630699, 18343036.
45. Kim YH, Park CK, Back SK, Lee CJ, Hwang SJ, Bae YC, Na HS, Kim JS, Jung SJ, Oh SB. Membrane-delimited coupling of TRPV1 and mGluR5 on presynaptic terminals of nociceptive neurons. J Neurosci 2009, 29:10000-10009. 10.1523/JNEUROSCI.5030-08.2009, 19675234.
46. Mizumura K, Sugiura T, Katanosaka K, Banik RK, Kozaki Y. Excitation and sensitization of nociceptors by bradykinin: what do we know?. Exp Brain Res 2009, 196:53-65. 10.1007/s00221-009-1814-5, 19396590.
47. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005, 1:3. 10.1186/1744-8069-1-3, 1074353, 15813989.
48. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60:135-148. 10.1016/j.brainresrev.2008.12.011, 2666786, 19150373.
49. Karim F, Bhave G, Gereau RW. Metabotropic glutamate receptors on peripheral sensory neuron terminals as targets for the development of novel analgesics. Mol Psychiatry 2001, 6:615-617. 10.1038/sj.mp.4000961, 11673787.
50. Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP. Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology 2011, 60:1017-41. 10.1016/j.neuropharm.2010.10.022, 21036182.
51. Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 1-21:3771-3779.
52. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001, 276:34631-34636. 10.1074/jbc.M104847200, 11457843.
53. Castellano JM, Navarro VM, Fernández-Fernández R, Castaño JP, Malagón MM, Aguilar E, Dieguez C, Magni P, Pinilla L, Tena-Sempere M. Ontogeny and mechanisms of action for the stimulatory effect of kisspeptin on gonadotropin-releasing hormone system of the rat. Mol Cell Endocrinol 2006, 257-258:75-83.
54. Oishi S, Misu R, Tomita K, Setsuda S, Masuda R, Ohno H, Naniwa Y, Ieda N, Inoue N, Ohkura S, Uenoyama Y, Tsukamura H, Maeda K, Hirasawa A, Tsujimoto G, Fujii N. Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. ACS Med Chem Lett 2011, 2:53-57.
55. Roumy M, Zajac JM. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 1998, 345:1-11. 10.1016/S0014-2999(97)01604-X, 9593588.
56. Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, Coulombe N, Tan CP, Tang-Nguyen AT, George SR, O'Dowd BF. Discovery of a receptor related to the galanin receptors. FEBS Lett 1999, 446(1):103-7. 10.1016/S0014-5793(99)00009-5, 10100623.